OGN News and Press, Organon & Co. From 05/02/24

2024-05-02 08:11:46 ET More on Organon Organon Stock Is Still Worth A Look Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last Organon & Co. (OGN) Q4 2023 Earnings Call Transcript Organon Non-GAAP EPS of $1.22 beats by $0.29, revenue ...

2024-05-02 07:32:09 ET More on Organon Organon Stock Is Still Worth A Look Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last Organon & Co. (OGN) Q4 2023 Earnings Call Transcript Organon Q1 2024 Earnings Preview AbbVie keeps ...

First quarter 2024 revenue of $1,622 million, up 5% on an as-reported basis and 7% at constant currency First quarter 2024 diluted earnings per share of $0.78 and non-GAAP Adjusted diluted earnings per share of $1.22; both reported and non-GAAP Adjusted diluted earnings per share include $15 ...

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

2024-05-01 11:26:45 ET Organon Stock Is Still Worth A Look Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last Organon & Co. (OGN) Q4 2023 Earnings Call Transcript AbbVie keeps Humira market share near 100% despite biosimilars: report ...

2024-04-28 08:00:00 ET As the calendar flips from April to May, the upcoming week is set to bring a flurry of earnings reports from some of the world's most prominent companies. At the top of the list, updates are anticipated from tech giants Amazon ( NASDAQ: AMZN ) and Apple ( NA...

2024-04-24 07:15:00 ET Summary Sound Shore Fund, Inc. is registered as a diversified, open-end management investment company. The investment objective of the Fund is growth of capital. The Sound Shore Fund Investor Class and Institutional Class advanced 17.05% and 17.10%, respecti...

2024-04-17 09:26:31 ET More on CVS Health CVS Health: Seizing Opportunity Amid Recent Declines CVS Health: Good Management Is Keeping Their Promises CVS Health: Here Comes The Floor - Inherent Undervaluation Triggers Great Upside Potential Dividend Roundup: P...

2024-04-13 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-13 10:52:04 ET More on AbbVie, Amgen, etc. AbbVie: Bulletproof Fundamentals AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67% UnitedHealth Q1 2024 Earnings Preview: Headwinds Not Enough To Derail This Juggernaut GLP-1s benefit Park...